摘要
目的:探索益肾祛浊方对多囊卵巢综合征胰岛素抵抗(PCOS-IR)模型大鼠激素及胰岛素受体表达的干预作用。方法:选取6~8周龄SPF级SD雌性大鼠60只随机分为空白组、模型组、益肾祛浊组、益肾组、西药组(达英-35联合二甲双胍),每组12只。空白组给予普通饲料喂养,其余各组均给予来曲唑灌胃联合高脂饲料喂养至第27天。然后给予不同药物灌胃2周,采用免疫荧光法检测各组大鼠雄激素受体(AR)、促黄体生成素受体(LHR)在卵巢、胃、肠组织的表达;并观察胰岛素受体(INSR)在卵巢的表达。结果:治疗14 d后发现,益肾祛浊方可以显著降低大鼠卵巢局部AR、LHR和INSR的表达,差异有统计学意义(P<0.05);且明显减少胃中AR及LHR的表达,差异有统计学意义(P<0.05);同时显著减少结肠组织LHR的表达,差异有统计学意义(P<0.05)。结论:益肾祛浊方可能通过降低AR、LHR表达而调整模型大鼠内分泌紊乱,又可通过降低INSR的表达,对PCOS-IR大鼠的代谢紊异常起到治疗作用。
Objective:To explore the intervention effects of Yishen Quzhuo Formula on the expression of hormones and insulin receptors in polycystic ovary syndrome model(PCOS-IR)rats.Methods:A total of 60 SPF level SD female rats aged 6-8 weeks were randomly divided into a blank group,a model group,a Yishen Quzhuo group,a Yishen Quzhuo group,and a Western medicine group(Diane-35 combined with metformin),with 12 rats in each group.The blank group was fed with normal diet,and the other groups were fed with letrozole by gavage combined with high-fat diet until the 27th day.Then,different drugs were fed by gavage for 2 weeks.The expression of androgen receptor(AR),luteinizing hormone receptor(LHR)in ovary,stomach and intestine and insulin receptor(INSR)in ovary were observed by immunofluorescence.Results:After 14 days of treatment,Yishen Quzhuo Formula could significantly reduce the expression of AR,LHR and INSR in part of ovary in rats(P<0.05),the expression of AR and LHR in stomach(P<0.05),and the expression of LHR in colon tissue(P<0.05).Conclusion:Yishen Quzhuo Formula may regulate endocrine disorders in model rats by lowering the expression of AR,LHR and further exert therapeutic effects on metabolic disorder of PCOS-IR rats by reducing the expression level of INSR.
作者
尹谦
王明星
许昕
YIN Qian;WANG Mingxing;XU Xin(Beijing University of Chinese Medicine,Beijing 100029,China;Beijing Hospital of Traditional Chinese Medicine,Capital Medical University,Beijing 100010,China)
出处
《世界中医药》
CAS
2020年第6期836-841,共6页
World Chinese Medicine
基金
国家自然科学基金项目(81674010)。